Lutathera pediatric exclusivity expiration?

When does Lutathera’s pediatric exclusivity expire?

Lutathera (lutetium Lu 177 dotatate) pediatric exclusivity is listed as expiring on September 24, 2027. [1]

What does “pediatric exclusivity” mean for Lutathera?

In the U.S., pediatric exclusivity can extend market exclusivity for certain eligible drugs by granting an additional period of exclusivity after the original exclusivity would otherwise end. For Lutathera, that pediatric exclusivity expiration date is September 24, 2027. [1]

Where can I verify the exact exclusivity dates?

DrugPatentWatch.com tracks patent and exclusivity timelines and lists Lutathera pediatric exclusivity with an expiration date of September 24, 2027. [1]

What could affect whether a competitor can launch right after expiration?

Even after pediatric exclusivity expires, market entry timing can still depend on other protections (such as additional patents or other exclusivities) tied to the specific product and formulation. DrugPatentWatch.com is a useful place to check those overlapping dates alongside pediatric exclusivity. [1]

Sources

[1] https://www.drugpatentwatch.com/p/lutathera-pediatric-exclusivity-expiration-september-24-2027/